AnalystsJudah FrommerJudah Frommer's Stock Forecasts
AnalystsJudah Frommer
Analyst Ranking
Top 28%
#1529 out of 5493 analysts
Average Return
+1.75%
Win Rate
52%68 out of 132
Risk vs Reward
Poor
Good
Judah Frommer's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Avidity Biosciences IncRNAM | +347.81% | $9.35 | $41.87 | 2023-08-09 - 2024-08-08 | Buy |
Stoke Therapeutics IncSTOK | +147.03% | $5.55 | $13.71 | 2023-08-08 - 2024-08-07 | Buy |
Trevi Therapeutics IncTRVI | +136.72% | $7.49 | $17.73 | 2025-08-21 - 2026-08-12 | Strong Buy |
Avidity Biosciences IncRNAM | +134.43% | $11.56 | $27.10 | 2023-05-10 - 2024-05-09 | Buy |
Ollie's Bargain Outlet Holdings IncOLLI | +129.14% | $38.78 | $88.86 | 2020-03-20 - 2020-05-26 | Buy |
Judah Frommer Analyst Color
Get additional color on Judah Frommer's coverage of popular stocks
Judah Frommer's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bicara Therapeutics IncBCAX | 3 | Strong Buy | $39.00 | +58.34% | Maintains | 18 hours ago |
Lakefront Biotherapeutics NvLKFT | 4 | Hold | $26.00 | -6.91% | Maintains | 2 days ago |
IMMIX Biopharma IncIMMX | 2 | Strong Buy | $19.00 | +67.11% | Maintains | 2 days ago |
Celldex Therapeutics IncCLDX | 4 | Strong Buy | $46.00 | +2.52% | Maintains | 6 days ago |
Compass Pathways PLCCMPS | 3 | Strong Buy | $18.00 | +26.58% | Maintains | 7 days ago |
Incyte CorpINCY | 1 | Hold | $104.00 | -13.89% | Maintains | 21 days ago |
Evommune IncEVMN | 3 | Strong Buy | $26.00 | +84.14% | Maintains | a month ago |
Engene Therapeutics IncENGN | 1 | Strong Sell | N/A | N/A | Downgrades | 2 months ago |
Abivax SaABVX | 5 | Strong Buy | $132.00 | +5.16% | Maintains | 2 months ago |
Avalyn Pharma IncAVLN | 1 | Strong Buy | $53.00 | +41.79% | Initiates Coverage On | 3 months ago |
Zenas Biopharma IncZBIO | 4 | Hold | $22.00 | -29.69% | Maintains | 3 months ago |
Kalaris Therapeutics IncKLRS | 1 | Strong Buy | $14.00 | +255.33% | Initiates Coverage On | 4 months ago |
Trevi Therapeutics IncTRVI | 3 | Strong Buy | $18.00 | +1.52% | Maintains | 5 months ago |
Regenxbio IncRGNX | 4 | Strong Buy | $17.00 | +55.82% | Maintains | 5 months ago |
Belite Bio IncBLTE | 2 | Strong Buy | $201.00 | +12.33% | Maintains | 5 months ago |
Agomab Therapeutics NvAGMB | 1 | Strong Buy | $28.00 | +98.44% | Initiates Coverage On | 5 months ago |
Genmab AGMAB | 1 | Hold | $34.00 | +8.21% | Reinstates | 6 months ago |
Apellis Pharmaceuticals IncAPLS | 2 | Hold | $26.00 | N/A | Maintains | a year ago |
Blueprint Medicines CorpBPMC | 2 | Hold | $129.00 | N/A | Maintains | a year ago |
4d Molecular Therapeutics IncFDMT | 2 | Strong Sell | $6.00 | N/A | Maintains | 2 years ago |
Arcellx IncACLX | 2 | Strong Buy | $106.00 | N/A | Maintains | 2 years ago |
Mural Oncology PLCMURA | 1 | Strong Buy | $13.00 | N/A | Initiates Coverage On | 2 years ago |
Prokidney CorpPROK | 1 | Hold | $3.00 | N/A | Assumes | 2 years ago |
Jasper Therapeutics IncJSPR | 8 | Buy | $40.00 | N/A | Reiterates | 3 years ago |
Akili IncAKLI | 3 | Buy | $4.00 | N/A | Reiterates | 3 years ago |
Acumen Pharmaceuticals IncABOS | 5 | Buy | $13.00 | N/A | Reiterates | 3 years ago |
Avidity Biosciences IncRNAM | 8 | Buy | $30.00 | N/A | Reiterates | 3 years ago |
Stoke Therapeutics IncSTOK | 5 | Buy | $23.00 | N/A | Reiterates | 3 years ago |
Ptc Therapeutics IncPTCT | 8 | Hold | $50.00 | N/A | Reiterates | 3 years ago |
Sarepta Therapeutics IncSRPT | 13 | Hold | $141.00 | N/A | Reiterates | 3 years ago |
Imagenebio IncIMA | 5 | Buy | $156.00 | N/A | Reiterates | 3 years ago |
Ataibeckley IncATAI | 5 | Buy | $9.00 | N/A | Reiterates | 3 years ago |
Effector Therapeutics IncEFTR | 6 | Buy | $137.50 | N/A | Maintains | 3 years ago |
Newamsterdam Pharma Co NvNAMS | 2 | Buy | $22.00 | N/A | Maintains | 3 years ago |
Candel Therapeutics IncCADL | 3 | Buy | $7.00 | N/A | Maintains | 3 years ago |
Pear Therapeutics IncPEARQ | 4 | Hold | $1.00 | N/A | Downgrades | 3 years ago |
Fulcrum Therapeutics IncFULC | 5 | Hold | $8.00 | N/A | Downgrades | 3 years ago |
Inhibrx IncINBX1 | 4 | Buy | $46.00 | N/A | Reiterates | 3 years ago |
Esperion Therapeutics IncESPR | 6 | Hold | $7.00 | N/A | Upgrades | 3 years ago |
Uniqure NvQURE | 3 | Buy | $55.00 | N/A | Maintains | 3 years ago |
Insmed IncINSM | 1 | Buy | $46.00 | N/A | Reiterates | 3 years ago |
Quince Therapeutics IncQNCX | 1 | Sell | $3.50 | N/A | Maintains | 4 years ago |
Flexion Therapeutics IncFLXN1 | 2 | Hold | $10.00 | N/A | Downgrades | 5 years ago |
Albertsons Companies IncACI | 1 | Buy | $18.00 | N/A | Initiates Coverage On | 6 years ago |
Five Below IncFIVE | 6 | Buy | $116.00 | N/A | Maintains | 6 years ago |
Ollie's Bargain Outlet Holdings IncOLLI | 4 | Hold | $90.00 | N/A | Downgrades | 6 years ago |
Us Foods Holding CorpUSFD | 3 | Buy | $23.00 | N/A | Maintains | 6 years ago |
Sysco CorpSYY | 3 | Buy | $63.00 | N/A | Maintains | 6 years ago |
Sprouts Farmers Market IncSFM | 1 | Hold | $22.00 | N/A | Maintains | 6 years ago |
Kroger CoKR | 6 | Hold | $35.00 | N/A | Maintains | 6 years ago |
Performance Food Group CoPFGC | 2 | Buy | $39.00 | N/A | Reinstates | 6 years ago |
Dollar Tree IncDLTR | 5 | Buy | $98.00 | N/A | Maintains | 6 years ago |
Bj's Wholesale Club Holdings IncBJ | 1 | Buy | $25.00 | N/A | Initiates Coverage On | 6 years ago |
Costco Wholesale CorpCOST | 1 | Hold | $328.00 | N/A | Initiates Coverage On | 6 years ago |
Dollar General CorpDG | 1 | Hold | $93.00 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.